The recent Cumberlege report, First Do No Harm,12 does not consider potential harms to patients from behavioural and […]
Pfizer sees ‘mostly mild to moderate’ safety profile in phase 3 COVID vaccine study esagonowsky Wed, 09/16/2020 – […]
Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine kblankenship Wed, 09/16/2020 – 09:19
Merck’s Seattle Genetics ADC deal extends blockbuster Keytruda franchise: analyst aliu Wed, 09/16/2020 – 08:59
Azithromycin — a commonly-prescribed antibiotic — also is being investigated as a potential treatment for COVID-19. Researchers have […]
A portable, low-field magnetic resonance imaging (MRI) device can be safely used at bedside in complex clinical care […]
According to the Federal Statistical Office of Germany, cancer is one of the most frequent causes of death, […]
The UK government has a “moral imperative” to take firm action against racism and health inequalities that have […]
The BMA must work to ensure that any future trade deal between the UK and the US does […]
